Real-World Use of Once-Weekly Semaglutide in Type 2 Diabetes: Results from the SURE UK Multicentre, Prospective, Observational Study-Reference-Cited by-同舟云学术

Real-World Use of Once-Weekly Semaglutide in Type 2 Diabetes: Results from the SURE UK Multicentre, Prospective, Observational Study

Published:2021-09-25 Issue:11 Volume:12 Page:2891-2905
ISSN:1869-6953
Container-title:Diabetes Therapy
language:en
Short-container-title:Diabetes Ther

Author:

Holmes Patrick^ORCID,Bell Heather Elizabeth,Bozkurt Karan,Catarig Andrei-Mircea,Clark Alice,Machell Alena,Sathyapalan Thozhukat

Funder

novo nordisk

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://link.springer.com/content/pdf/10.1007/s13300-021-01141-8.pdf

Reference40 articles.

1. Diabetes UK. Number of people with diabetes reaches 4.8 million. 2019. https://www.diabetes.org.uk/about_us/news/diabetes-prevalence-2019. Accessed 17 Aug 2021.

2. Davies MJ, D’Alessio DA, Fradkin J, et al. Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2018;61:2461–98.

3. American Diabetes Association. Standards of medical care in diabetes—2021. Diabetes Care. 2021;44(Suppl 1):S1–232.

4. National Institute for Health and Care Excellence. Type 2 diabetes in adults: management [NG28] 2015 (NICE clinical guidelines, updated December 2020). https://www.nice.org.uk/guidance/ng28. Accessed 17 Aug 2021.

5. Buse JB, Wexler DJ, Tsapas A, et al. 2019 Update to: management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2020;63:221–8.

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real‐world safety profile of once‐weekly semaglutide in people with type 2 diabetes: Analysis of pooled data from the SemaglUtide Real‐world Evidence (SURE) programme;Diabetes, Obesity and Metabolism;2024-08-08

2. Real-World Evaluation of Once-Weekly Subcutaneous Semaglutide in Patients with Type 2 Diabetes Mellitus in Spain (SEMA-RW Study);Nutrients;2024-08-03

3. Effectiveness and safety of once-weekly semaglutide: findings from the SEMACOL-REAL retrospective multicentric observational study in Colombia;Frontiers in Endocrinology;2024-06-25

4. Glycemic Control and Body Weight Reduction with Once-Weekly Semaglutide in Colombian Adults with Type 2 Diabetes: Findings from the COLIBRI Study;Diabetes Therapy;2024-04-30

5. Effectiveness and safety of drugs for obesity;BMJ;2024-03-25